Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleSpecial Section: From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function – Minireview
Open Access

Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3

Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
Molecular Pharmacology December 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954
Vladimir Bobkov
Division of Medicinal Chemistry, Amsterdam Institute for Molecules Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (V.B., M.A., A.Z., T.W.M.D.G., M.J.S.); and argenx BVBA, Zwijnaarde, Belgium (V.B., B.W., H.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Arimont
Division of Medicinal Chemistry, Amsterdam Institute for Molecules Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (V.B., M.A., A.Z., T.W.M.D.G., M.J.S.); and argenx BVBA, Zwijnaarde, Belgium (V.B., B.W., H.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aurélien Zarca
Division of Medicinal Chemistry, Amsterdam Institute for Molecules Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (V.B., M.A., A.Z., T.W.M.D.G., M.J.S.); and argenx BVBA, Zwijnaarde, Belgium (V.B., B.W., H.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timo W.M. De Groof
Division of Medicinal Chemistry, Amsterdam Institute for Molecules Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (V.B., M.A., A.Z., T.W.M.D.G., M.J.S.); and argenx BVBA, Zwijnaarde, Belgium (V.B., B.W., H.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bas van der Woning
Division of Medicinal Chemistry, Amsterdam Institute for Molecules Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (V.B., M.A., A.Z., T.W.M.D.G., M.J.S.); and argenx BVBA, Zwijnaarde, Belgium (V.B., B.W., H.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans de Haard
Division of Medicinal Chemistry, Amsterdam Institute for Molecules Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (V.B., M.A., A.Z., T.W.M.D.G., M.J.S.); and argenx BVBA, Zwijnaarde, Belgium (V.B., B.W., H.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martine J. Smit
Division of Medicinal Chemistry, Amsterdam Institute for Molecules Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (V.B., M.A., A.Z., T.W.M.D.G., M.J.S.); and argenx BVBA, Zwijnaarde, Belgium (V.B., B.W., H.H.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 96 no. 6 753-764
DOI 
https://doi.org/10.1124/mol.119.116954
PubMed 
31481460

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received April 22, 2019
  • Accepted July 3, 2019
  • Published online November 15, 2019.

Article Versions

  • Earlier version (September 3, 2019 - 11:31).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2019 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.

Author Information

  1. Vladimir Bobkov,
  2. Marta Arimont,
  3. Aurélien Zarca,
  4. Timo W.M. De Groof,
  5. Bas van der Woning,
  6. Hans de Haard, and
  7. Martine J. Smit
  1. Division of Medicinal Chemistry, Amsterdam Institute for Molecules Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (V.B., M.A., A.Z., T.W.M.D.G., M.J.S.); and argenx BVBA, Zwijnaarde, Belgium (V.B., B.W., H.H.)
  1. Address correspondence to:
    Martine J. Smit, Division of Medicinal Chemistry, Amsterdam Institute for Molecules, Medicines and Systems, Vrije Universiteit Amsterdam, Amsterdam, De Boelelaan 1108, 1081 HZ Amsterdam, The Netherlands. E-mail: mj.smit{at}vu.nl
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: September 2019 to January 2021

AbstractFullPdf
Sep 20193880232
Oct 20191450100
Nov 201966162107
Dec 20193815570
Jan 20201815057
Feb 2020198962
Mar 20201611068
Apr 202014146131
May 2020168458
Jun 2020149386
Jul 20201110858
Aug 202058468
Sep 202099282
Oct 2020815398
Nov 202037073
Dec 2020134854
Jan 202144342

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 96 (6)
Molecular Pharmacology
Vol. 96, Issue 6
1 Dec 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleSpecial Section: From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function – Minireview

Antibodies Targeting CXCR4 and ACKR3

Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
Molecular Pharmacology December 1, 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleSpecial Section: From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function – Minireview

Antibodies Targeting CXCR4 and ACKR3

Vladimir Bobkov, Marta Arimont, Aurélien Zarca, Timo W.M. De Groof, Bas van der Woning, Hans de Haard and Martine J. Smit
Molecular Pharmacology December 1, 2019, 96 (6) 753-764; DOI: https://doi.org/10.1124/mol.119.116954
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Targeting CXCR4 and ACKR3 with Antibodies
    • Single-Domain Antibodies as Therapeutics and Tools in GPCR Research
    • Structural Analysis of Antibodies/Nanobodies Binding to CXCR4
    • Conclusions
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • ACKR3 Expression and Function in the Immune System
  • ACKR3 in Breast, Lung, and Brain Cancer
  • Modulators of CXCR4 and CXCR7/ACKR3 Function
Show more Special Section: From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function – Minireview

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics